BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8611728)

  • 1. Quantitation of mafosfamide-resistant pre-colony-forming units in allogeneic bone marrow transplantation: relationship with rate of engraftment and evidence for long-lasting reduction in stem cell numbers.
    Kirkland MA; Spencer A; Davidson RJ; McDonald C; Goldman JM
    Blood; 1996 May; 87(9):3963-9. PubMed ID: 8611728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The contribution of cytotoxic and noncytotoxic function by donor T-cells that support engraftment after allogeneic bone marrow transplantation.
    Jiang Z; Adams GB; Hanash AM; Scadden DT; Levy RB
    Biol Blood Marrow Transplant; 2002; 8(11):588-96. PubMed ID: 12463477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation.
    Carlo-Stella C; Mangoni L; Almici C; Garau D; Craviotto L; Piovani G; Caramatti C; Rizzoli V
    Exp Hematol; 1992 Mar; 20(3):328-33. PubMed ID: 1568448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in both the hematopoietic microenvironment and the progenitor cell population follow the recovery from myeloablative therapy and bone marrow transplantation.
    Novitzky N; Mohamed R
    Exp Hematol; 1995 Dec; 23(14):1661-6. PubMed ID: 8542962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of recombinant human granulocyte-macrophage colony-stimulating factor in patients with lymphoid malignancies transplanted with unpurged or adjusted-dose mafosfamide-purged autologous marrow.
    Carlo-Stella C; Mangoni L; Almici C; Cottafavi L; Meloni G; Mandelli F; Rizzoli V
    Blood; 1992 Nov; 80(9):2412-8. PubMed ID: 1421413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of recombinant cytokines for enhancing immunohematopoietic reconstitution following bone marrow transplantation. II. The influence of lymphokines on CFU-GM colonies from human untreated, ASTA-Z or Campath-1M treated bone marrow.
    Mumcuoglu M; Naparstek E; Slavin S
    Bone Marrow Transplant; 1990 Mar; 5(3):153-8. PubMed ID: 2184907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of marrow CFU-GM content on engraftment and survival after allogeneic bone marrow transplantation.
    Bacigalupo A; Piaggio G; Podesta M; Figari O; Benvenuto F; Sogno G; Tedone E; Raffo MR; Grassia L; Ferrero R
    Bone Marrow Transplant; 1995 Feb; 15(2):221-6. PubMed ID: 7773210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonogenic assays and engraftment in allogeneic bone marrow transplantation.
    Gerhartz HH; Kolb HJ; Clemm C; Wilmanns W
    Bone Marrow Transplant; 1986 Dec; 1(2):221-6. PubMed ID: 2901871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.
    Papadakis V; Ferguson KF; Heller G; Kernan NA
    Exp Hematol; 1995 Dec; 23(14):1422-30. PubMed ID: 8542927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of the spleen on compartmental levels and distribution of donor progenitor cells after syngeneic and allogeneic bone marrow transplants.
    Shatry AM; Jones M; Levy RB
    Stem Cells Dev; 2004 Feb; 13(1):51-62. PubMed ID: 15068693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive value of colony-forming unit assays for engraftment and leukemia-free survival after transplantation of chemopurged syngeneic bone marrow in rats.
    Wiley JM; Yeager AM
    Exp Hematol; 1991 Mar; 19(3):179-84. PubMed ID: 1704843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-lasting decrease of marrow and circulating long-term culture initiating cells after allogeneic bone marrow transplant.
    Selleri C; Maciejewski JP; De Rosa G; Raiola A; Risitano AM; Picardi M; Pezzullo L; Luciano L; Ricci P; Varriale G; Della Cioppa P; Del Vecchio L; Rotoli B
    Bone Marrow Transplant; 1999 May; 23(10):1029-37. PubMed ID: 10373069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of recombinant human stem cell factor on mafosfamide-treated bone marrow clonogenic cells.
    Carlo-Stella C; Mangoni L; Almici C; Caramatti C; Rizzoli V
    Stem Cells; 1993 Jul; 11 Suppl 2():170-4. PubMed ID: 7691323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor marrow progenitors (CFU-Mix, BFU-E and CFU-GM) and haemopoietic engraftment following HLA matched sibling bone marrow transplantation.
    Ma DD; Varga DE; Biggs JC
    Leuk Res; 1987; 11(2):141-7. PubMed ID: 3546956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Juvenile chronic myelogenous leukemia: in vitro characterization before and after allogeneic bone marrow transplantation.
    Zecca M; Rosti V; Pinto L; Comoli P; CarrĂ  AM; Prete L; Bonetti F; Pedrazzoli P; Locatelli F; Cazzola M
    Med Pediatr Oncol; 1995 Mar; 24(3):166-70. PubMed ID: 7838038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does the granulocyte-macrophage colony-forming unit content in ex vivo-expanded grafts predict the recovery of the recipient leukocytes?
    Albella B; Segovia JC; Bueren JA
    Blood; 1997 Jul; 90(1):464-70. PubMed ID: 9207484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors affecting the mobilization of primitive and committed hematopoietic progenitors into the peripheral blood of cancer patients.
    Schneider JG; Crown JP; Wasserheit C; Kritz A; Wong G; Reich L; Norton L; Moore MA
    Bone Marrow Transplant; 1994 Dec; 14(6):877-84. PubMed ID: 7536069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow mononuclear cell count does not predict neutrophil and platelet recovery following autologous bone marrow transplant: value of the colony-forming unit granulocyte-macrophage (CFU-GM) assay.
    al-Fiar F; Prince HM; Imrie K; Stewart AK; Crump M; Keating A
    Cell Transplant; 1997; 6(5):491-5. PubMed ID: 9331500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up after allogeneic granulocyte colony-stimulating factor--primed bone marrow transplantation.
    Isola L; Scigliano E; Fruchtman S
    Biol Blood Marrow Transplant; 2000; 6(4A):428-33. PubMed ID: 10975511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Difference in kinetics of hematopoietic reconstitution between ALL and ANLL after autologous bone marrow transplantation with marrow treated in vitro with mafosfamide (ASTA Z 7557).
    Douay L; Laporte JP; Mary JY; Lopez M; Lemonnier MP; Stachowiak J; Benitez O; Deloux J; Najman A; Salmon C
    Bone Marrow Transplant; 1987 Jun; 2(1):33-43. PubMed ID: 3332155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.